Cardiovascular Disease and Adiposity
Cardiovascular Disease and Adiposity is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 40k research works in it since 1950. 14.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the role of perivascular adipose tissue in cardiovascular health, particularly its involvement in vascular function, inflammation, and the development of cardiovascular diseases such as atherosclerosis and coronary artery disease. The research explores the impact of adipocytokines, the relationship with endothelial function, and the influence of obesity on perivascular adipose tissue.
- Perivascular Adipose Tissue
- Epicardial Fat
- Vascular Function
- Inflammation
- Cardiovascular Disease
- Adipocytokines
- Atherosclerosis
- Coronary Artery Disease
- Endothelial Function
- Obesity
- Research works
- 40k fractional, since 1950
- In the world top 10%
- 5.6k per year above
- Top-10% rate
- 14.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +24% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiovascular Disease and Adiposity research?
By volume, the United States and China publish the most (2.3k and 1.6k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.3k works
- 2 China 1.6k works
- 3 Russia 406 works
- 4 India 400 works
- 5 Japan 320 works
- 6 United Kingdom 310 works
- 7 Italy 307 works
- 8 Türkiye 255 works
- 9 Germany 205 works
- 10 Egypt 203 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiovascular Disease and Adiposity research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Cardiovascular Disease and Adiposity research, followed by University of North Carolina at Chapel Hill and Johns Hopkins University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49 works
- 2 University of North Carolina at Chapel HillUnited States 42 works
- 3 Johns Hopkins UniversityUnited States 36 works
- 4 Cedars-Sinai Medical CenterUnited States 32 works
- 5 Massachusetts General HospitalUnited States 32 works
- 6 Brigham and Women's HospitalUnited States 31 works
- 7 Capital Medical UniversityChina 30 works
- 8 Harvard UniversityUnited States 30 works
- 9 Zagazig UniversityEgypt 27 works
- 10 Nanjing Medical UniversityChina 24 works
Who are the leading researchers in Cardiovascular Disease and Adiposity?
The most-cited researchers publishing on Cardiovascular Disease and Adiposity include Walter C. Willett, Emelia J. Benjamin and William B. Kannel.
- 1 Walter C. Willett United States 6.8k citations
- 2 Emelia J. Benjamin United States 6k citations
- 3 William B. Kannel United States 5.7k citations
- 4 Valentı́n Fuster United States 5.4k citations
- 5 Josef Coresh United States 5.3k citations
- 6 Winfried März Germany 5.2k citations
- 7 Philimon Gona United States 5.1k citations
- 8 Mark I. McCarthy United Kingdom 4.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiovascular Disease and Adiposity research done?
The largest centres of Cardiovascular Disease and Adiposity research in 2022–2025 are Beijing (China), Shanghai (China), Moscow (Russia) and Boston (United States).
Largest cities, 2022–2025
Where is the best place to study Cardiovascular Disease and Adiposity?
Among universities, judged by research, Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș, Chinese Academy of Medical Sciences & Peking Union Medical College and Nanjing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu MureșRomania | 70.7 | 30.6% | 16.2× | 12 | +374.6% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 65.1 | 23.0% | 5.6× | 49 | +131.4% |
| 3 | Nanjing Medical UniversityChina | 52.6 | 26.6% | 5.3× | 24 | +31.3% |
| 4 | Zagazig UniversityEgypt | 52.1 | 0.0% | 7.8× | 27 | +279.5% |
| 5 | Augusta UniversityUnited States | 51.9 | 7.6% | 12.1× | 14 | +143.2% |
| 6 | Victor Babeș University of Medicine and Pharmacy TimișoaraRomania | 51.9 | 13.7% | 10.6× | 9 | +175.2% |
| 7 | National and Kapodistrian University of AthensGreece | 50.0 | 24.5% | 3.5× | 16 | +120.5% |
| 8 | Shanghai Jiao Tong UniversityChina | 48.3 | 29.3% | 1.0× | 20 | +119.9% |
| 9 | Capital Medical UniversityChina | 48.0 | 16.8% | 5.8× | 30 | +20.4% |
| 10 | Harvard UniversityUnited States | 47.3 | 20.7% | 2.6× | 30 | +20.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiovascular Disease and Adiposity research growing?
Output in 2018–2022 was 24% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cardiovascular Disease and Adiposity.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.